Based on limited published evidence, RPL17-C18orf32 is a readthrough chimeric RNA with emerging roles in disease-related pathways. In Alzheimer's disease research, RPL17-C18orf32 was identified among top differentially expressed genes in cognitively intact individuals accumulating cortical amyloid, with high direct association scores for pathogenic involvement 1. Functionally, RPL17-C18orf32 mediates polycyclic aromatic hydrocarbon (benzo[ghi]perylene)-induced respiratory toxicity through the CYP1A1/RPL17-C18orf32 axis, where it promotes DNA damage, cell cycle arrest, and apoptosis in bronchial epithelial cells and lung tissue 2. Knockdown of RPL17-C18orf32 attenuates toxicity, while overexpression exacerbates harmful effects.